COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05054582 |
|
Recruitment Status :
Active, not recruiting
First Posted : September 23, 2021
Last Update Posted : March 6, 2024
|
Sponsor:
Medical University Innsbruck
Collaborators:
Queen's University, Belfast
European Cystic Fibrosis Society - Clinical Trial Network
Cystic Fibrosis Foundation
Information provided by (Responsible Party):
Medical University Innsbruck
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | September 30, 2024 |
| Estimated Study Completion Date : | November 30, 2024 |